IL107268A0 - Molecules influencing the shedding of the tnf receptor, their preparation and their use - Google Patents

Molecules influencing the shedding of the tnf receptor, their preparation and their use

Info

Publication number
IL107268A0
IL107268A0 IL107268A IL10726893A IL107268A0 IL 107268 A0 IL107268 A0 IL 107268A0 IL 107268 A IL107268 A IL 107268A IL 10726893 A IL10726893 A IL 10726893A IL 107268 A0 IL107268 A0 IL 107268A0
Authority
IL
Israel
Prior art keywords
shedding
preparation
tnf receptor
tnf
molecules
Prior art date
Application number
IL107268A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL107268A priority Critical patent/IL107268A0/xx
Publication of IL107268A0 publication Critical patent/IL107268A0/xx
Priority to CA002133872A priority patent/CA2133872A1/en
Priority to PT94116018T priority patent/PT657536E/pt
Priority to AT94116018T priority patent/ATE203273T1/de
Priority to DE69427740T priority patent/DE69427740T2/de
Priority to EP94116018A priority patent/EP0657536B1/de
Priority to ES94116018T priority patent/ES2163418T3/es
Priority to DK94116018T priority patent/DK0657536T3/da
Priority to AU75742/94A priority patent/AU679559B2/en
Priority to ZA947962A priority patent/ZA947962B/xx
Priority to US08/321,668 priority patent/US5665859A/en
Priority to JP6274532A priority patent/JPH07194376A/ja
Priority to US08/837,941 priority patent/US5766917A/en
Priority to GR20010401643T priority patent/GR3036782T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
IL107268A 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use IL107268A0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL107268A IL107268A0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use
CA002133872A CA2133872A1 (en) 1993-10-12 1994-10-07 Molecules influencing the shedding of the tnf receptor, their preparation and their use
AU75742/94A AU679559B2 (en) 1993-10-12 1994-10-11 Molecules influencing the shedding of the TNF receptor, their preparation and their use
ES94116018T ES2163418T3 (es) 1993-10-12 1994-10-11 Inhibidores de una proteasa que es capaz de separar el receptor tnf soluble p55 del receptor tnf unido a la celula.
AT94116018T ATE203273T1 (de) 1993-10-12 1994-10-11 Inhibitoren einer protease, die den löslichen p55-tnf-rezeptor vom zellgebundenen tnf-rezeptor abspaltet
DE69427740T DE69427740T2 (de) 1993-10-12 1994-10-11 Inhibitoren einer Protease, die den löslichen p55-TNF-Rezeptor vom zellgebundenen TNF-Rezeptor abspaltet
EP94116018A EP0657536B1 (de) 1993-10-12 1994-10-11 Inhibitoren einer Protease, die den löslichen p55-TNF-Rezeptor vom zellgebundenen TNF-Rezeptor abspaltet
PT94116018T PT657536E (pt) 1993-10-12 1994-10-11 Inibidores de uma protease que e capaz de clivar o receptor soluvel p55 de fnt separando-o do receptor de fnt ligado as celulas
DK94116018T DK0657536T3 (da) 1993-10-12 1994-10-11 Inhibitorer for en protease, som er i stand til at spalte den opløselige p55-receptor fra cellebundet TNF-receptor
ZA947962A ZA947962B (en) 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor their preparation and their use
US08/321,668 US5665859A (en) 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor, their preparation and their use
JP6274532A JPH07194376A (ja) 1993-10-12 1994-10-12 受容体の脱離に影響を及ぼす分子およびその調製法
US08/837,941 US5766917A (en) 1993-10-12 1997-04-28 Method for identifying and producing a protease capable of cleaving the TNF receptor
GR20010401643T GR3036782T3 (en) 1993-10-12 2001-10-03 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL107268A IL107268A0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Publications (1)

Publication Number Publication Date
IL107268A0 true IL107268A0 (en) 1994-01-25

Family

ID=11065340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107268A IL107268A0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Country Status (13)

Country Link
US (2) US5665859A (de)
EP (1) EP0657536B1 (de)
JP (1) JPH07194376A (de)
AT (1) ATE203273T1 (de)
AU (1) AU679559B2 (de)
CA (1) CA2133872A1 (de)
DE (1) DE69427740T2 (de)
DK (1) DK0657536T3 (de)
ES (1) ES2163418T3 (de)
GR (1) GR3036782T3 (de)
IL (1) IL107268A0 (de)
PT (1) PT657536E (de)
ZA (1) ZA947962B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03164179A (ja) * 1989-04-21 1991-07-16 Boehringer Ingelheim Internatl Gmbh Ｔｎｆレセプター、ｔｎｆ結合たん白質およびこれらをコードするｄｎａ
US7264944B1 (en) * 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
BR9712900A (pt) 1996-11-06 2000-11-28 Univ California Enzima liberadora de receptor de fator de necrose de tumor isolado, composições que compreendem a enzima e métodos de utilização da mesma
US6989435B2 (en) * 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6406907B1 (en) * 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
US7135303B2 (en) 2000-02-28 2006-11-14 The United States Of America As Represented By The Department Of Health And Human Services Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
US7785834B2 (en) * 2005-11-10 2010-08-31 Ercole Biotech, Inc. Soluble TNF receptors and their use in treatment of disease
KR101789603B1 (ko) * 2005-11-10 2017-11-21 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 Ｔｎｆ 수퍼패밀리 수용체에 대한 스플라이스 스위칭올리고머 및 염증성 질환 치료용 약제학적 조성물
US8268635B2 (en) * 2006-05-19 2012-09-18 Antonio Ferrante Methods of identifying agents that selectively activate p38 and/or NKkB signaling
US20090264353A1 (en) * 2007-10-19 2009-10-22 Santaris Pharma A/S Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
EP2492281B1 (de) * 2009-10-19 2018-04-11 HanAll Biopharma Co., Ltd. Modifiziertes menschliches tumornekrose-faktor-rezeptor-1-polypeptid oder fragment davon sowie herstellungsverfahren dafür
US11021339B2 (en) 2017-05-22 2021-06-01 Bedford Industries, Inc. Elastic band dispenser
US10723532B2 (en) 2017-05-22 2020-07-28 Bedford Insutries, Inc. Elastic band package

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action

Also Published As

Publication number Publication date
GR3036782T3 (en) 2002-01-31
EP0657536A1 (de) 1995-06-14
US5766917A (en) 1998-06-16
DK0657536T3 (da) 2001-09-17
ATE203273T1 (de) 2001-08-15
AU679559B2 (en) 1997-07-03
DE69427740D1 (de) 2001-08-23
EP0657536B1 (de) 2001-07-18
PT657536E (pt) 2001-12-28
ZA947962B (en) 1995-11-21
CA2133872A1 (en) 1995-04-13
AU7574294A (en) 1995-05-04
JPH07194376A (ja) 1995-08-01
DE69427740T2 (de) 2002-05-23
US5665859A (en) 1997-09-09
ES2163418T3 (es) 2002-02-01

Similar Documents

Publication Publication Date Title
ZA947962B (en) Molecules influencing the shedding of the TNF receptor their preparation and their use
DE69435198D1 (de) "hedgehog-like" proteine von wirbeltieren, die embryonale strukturen induzieren
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
WO1999012965A3 (en) April- a novel protein with growth effects
CA2161808A1 (en) Bmp-11 compositions
EP0442724A3 (en) Modified hil-6
FI941459A0 (fi) Tuumorinekroositekijän muteiineja
ATE307204T1 (de) Tumor-nekrose-faktor ähnliches ligand
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
CA2163361A1 (en) Therapeutic substituted guanidines
AP9600782A0 (en) Recombinant il,4 antibodies useful in treatment of il,4 mediated disorders
AU8143894A (en) Mck-10 (mammary carcinoma kinase 10), a receptor tyrosine kinase
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
UA85365C2 (ru) Продукт конъюгирования цитокина для использования в противораковой терапии
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
GB2275683B (en) Tumor necrosis factor muteins
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
WO1990006943A3 (de) Neue tnf-peptide
GR3033468T3 (en) TNF inhibitors.
ITTO920516A0 (it) Procedimento ed apparecchiatura per la rpoduzione, in particolare domestica, di bevande.
AP9701142A0 (en) 4,4-(Disubstituted) cyclohexan-1-ols monomers and related compounds.
HUP0002304A2 (hu) Állatok májából kivonható fehérjék alkalmazása tumor nekrózis faktor túltermelődéssel járó kóros állapotok kezelésére használható gyógyászati készítmények előállítására
DE69432444D1 (de) Promotor-Sequenz des Rezeptors p55 für Tumor-Nekrosis-Faktor
ZA918116B (en) Inhibitors for the formation of tumor necrosis factor,processes for the preparation thereof and the use thereof
FI900578A0 (fi) Krydda.